The Pharmacy and Poisons Board (PPB) has issued a public alert over a falsified batch of a cancer treatment drug circulating in the Kenyan market, raising safety concerns for patients and healthcare providers. According to a public alert released on May 25, 2026, routine post-marketing surveillance detected a falsified product in circulation. “During the course